InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Explore the complete record of transactions filed by Alexander Robert, Chairman & CEO. Officer active across 2 companies, notably Allakos Inc.. Aggregated, 13 reports have been logged. Total volume traded: €6.9m. The latest transaction was filed on 2 June 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations13 total
€20,6788,084 shares@ €2.55790.3% of flow
Common Stock
SEC:0001209191-22-034344:0·
€39,7008,215 shares@ €4.83260.6% of flow
Common Stock
SEC:0001209191-22-015365:0·
0529,323 shares0
Common Stock
SEC:0001209191-22-014108:0·
051,681 shares0
Common Stock
SEC:0001209191-21-067796·
051,681 shares0
Common Stock
SEC:0001209191-21-067796:0·
€307,5533,985 shares@ €77.177712.0% of flow
Common Stock
SEC:0001209191-21-054719·
€307,5533,985 shares@ €77.17774.8% of flow
Common Stock
SEC:0001209191-21-054719:0·
€1m14,516 shares@ €73.881141.9% of flow
Common Stock
SEC:0001209191-21-038464·
€1m14,516 shares@ €73.881116.9% of flow
Common Stock
SEC:0001209191-21-038464:0·
€1m14,516 shares@ €81.279246.1% of flow
Common Stock
SEC:0001209191-21-036143·
€1m14,516 shares@ €81.279218.6% of flow
Common Stock
SEC:0001209191-21-036143:0·
€1m14,516 shares@ €81.2792100.0% of flow
Common Stock
SEC:0001209191-21-034236·
€1m14,516 shares@ €81.279218.6% of flow
Common Stock
SEC:0001209191-21-034236:0·
13 of 13 declarations
About Alexander Robert
Alexander Robert is the Chief Executive Officer of Allakos Inc., a company focused on developing treatments for immune diseases. Under his leadership, Allakos emphasizes innovation and improving patient outcomes. He plays a key role in the company's strategy and vision, ensuring that growth and development objectives are met.
